A Frailty-Adjusted Stratification Score to Predict Surgical Risk, Post-Operative, Long-Term Functional Outcome, and Quality of Life After Surgery in Intracranial Meningiomas
Overview
Authors
Affiliations
Object: To investigate those parameters affecting early and follow-up functional outcomes in patients undergoing resection of meningiomas and to design a dedicated predictive score, the Milan Bio(metric)-Surgical Score (MBSS) is hereby presented. Methods: Patients undergoing transcranial surgery for intracranial meningiomas were included. The most significant parameters in the regression analyses were implemented in a patient stratification score and were validated by testing its classification consistency with a clinical−radiological grading scale (CRGS), Milan complexity scale (MCS), and Charlson Comorbidity Index (CCI) scores. Results: The ASA score, Frailty index, skull base and posterior cranial fossa locations, a diameter of >25 mm, and the absence of a brain−tumour interface were predictive of early post-operative deterioration and were collected in MBSS Part A (AUC: 0.965; 95%C.I. 0.890−1.022), while the frailty index, posterior cranial fossa location, a diameter of >25 mm, a edema/tumour volume index of >2, dural sinus invasion, DWI hyperintensity, and the absence of a brain−tumour interface were predictive of a long-term unfavourable outcome and were collected in MBSS Part B (AUC: 0.877; 95%C.I. 0.811−0.942). The score was consistent with CRGS, MCS, and CCI. Conclusion: Patients’ multi-domain evaluation and the implementation of frailty indexes might help predict the perioperative complexity of cases; the functional, clinical, and neurological early outcomes; survival; and overall QoL after surgery.
Determinants of quality of life following resection of skull base tumors: a systematic review.
Sperl V, Rhomberg T, Kretschmer T Front Oncol. 2025; 14:1473261.
PMID: 39759154 PMC: 11696366. DOI: 10.3389/fonc.2024.1473261.
Schwartz C, Ueberschaer M, Rautalin I, Grauvogel J, Bissolo M, Masalha W J Neurooncol. 2024; 170(1):89-100.
PMID: 39230803 PMC: 11447097. DOI: 10.1007/s11060-024-04780-6.
Ius T, Raffa G, Aiudi D, Panciani P, Pepa G, Pessina F Neurosurg Rev. 2024; 47(1):373.
PMID: 39083092 PMC: 11291526. DOI: 10.1007/s10143-024-02524-8.
San A, Rahman R, Sanmugananthan P, Dube M, Panico N, Ariwodo O Cancers (Basel). 2023; 15(19).
PMID: 37835374 PMC: 10571784. DOI: 10.3390/cancers15194680.
Qureshi H, Tabor J, Pickens K, Lei H, Vasandani S, Jalal M J Neurooncol. 2023; 164(2):299-308.
PMID: 37624530 PMC: 10522517. DOI: 10.1007/s11060-023-04416-1.